Macleods Pharmaceuticals is recalling 32 lots of losartan potassium USP tablets and losartan potassium/hydrochlorothiazide (HCTZ) combination tablets after discovering trace amounts of the potential ...
The angiotensin receptor blocker (ARB) losartan led to hypotension and failed to improve mortality in patients hospitalized for acute COVID-19, according to the randomized, prospective -- and ...
Recalls continue to roll in as part of the US Food and Drug Administration’s investigation into angiotensin II receptor blockers (ARBs)—specifically valsartan, losartan, and irbesartan—contaminated ...
This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. NEW YORK — A widespread recall of common ...
February 9, 2011 (London, United Kingdom) — Substituting a generic angiotensin-receptor blocker (ARB), losartan, for the more expensive, branded ARB candesartan (Amias, Takeda) could save the UK ...
This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. NEW YORK — A widespread recall of common ...
Three ARBs were recalled by the US Food and Drug Administration in 2018 because of trace amounts of the potential carcinogen nitrosamine, but a sudden spike in reports of cancers among ARB users was ...
Detailed price information for Scienture Holdings Inc (SCNX-Q) from The Globe and Mail including charting and trades.
The Food and Drug Administration will allow certain lots of the blood pressure drug losartan that contain trace amounts of a potential carcinogen to be shipped to pharmacies. The temporary measure is ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback